Clinical Research Philadelphia, LLC

Philadelphia, Pennsylvania 19114

0 studies enrolling now · 4 studies all time

What they study most

Acute Migraine, Chronic Spontaneous Urticaria, Episodic Migraine, Migraine, Phonophobia, Photophobia

Studies at this site

• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria — Running, not enrolling
• Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention — Completed
• A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine — Completed
• A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention — Stopped early